Plasmapherese und Immunadsorption - ExThera Medical

Fill in our contact form

Seraph 100
- Seraph 100
- Our technology
COVID-19 & Seraph
- COVID-19 & Seraph
- Clinical Trials
About ExThera Medical
News
Events
USA
Contact

Seraph 100
- Seraph 100
- Our technology
COVID-19 & Seraph
- COVID-19 & Seraph
- Clinical Trials
About ExThera Medical
News
Events
USA
Contact

menu

Event; Plasmapherese und Immunadsorption, November 13, 2021

Stay up to date

Join our newsletter by filling in the fields below

Name*
Email address*

Contact

ExThera Medical Europe BV

Selzerbeeklaan 3b
6291 HV, Vaals
The Netherlands

Tel: + 31 43 8200399
Fax: + 31 43 8200399

Navigation

Seraph 100
- Seraph 100
- Our technology
COVID-19 & Seraph
- COVID-19 & Seraph
- Clinical Trials
About ExThera Medical
News
Events
USA
Contact

Partners / Certifications

Socials

News

Patient Enrollment is Complete in the DOD-Funded Study of...
Treatment for critically ill COVID patients results in si...
ExThera Medical and Asahi Kasei Medical Enter into Partne...
How to save a life: Local firefighter with COVID-19 gets ...
Absorption of Circulating Tumor Cells by Hemoperfusion

© 2022 ExThera Medical | Webdevelopment by webmix

The Seraph 100 Microbind Affinity Blood Filter (Seraph 100) is CE Marked and approved for commercial sale in Europe. | Privacy policy